Navigation Links
Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
Date:2/25/2008

underserved portal hypertension market."

About Dong-A PharmTech Co., Ltd.

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.

Statements under the Private Securities Litigation Reform Act: with the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to FDA review and approval, product development and acceptance, manufacturing, competition, and/or other factors, which are outside the control of the Company.

Contact:

Mr. Chan Won OH

Director, International Product Development Team

252, Yongdu-Dong, Dongdaemun-Ku

Seoul 130-078, Korea

Tel: +82 2 920 8220

Fax: +82 2 925 4026

Email: ocw@donga.co.kr


'/>"/>
SOURCE Dong-A PharmTech Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MacuSight(TM) Announces Positive Preliminary Results From Phase 1 Study of Sirolimus in Wet Age-Related Macular Degeneration
2. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
3. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
4. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
5. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
6. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
7. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
8. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
9. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
10. Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
11. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 A new report by ... seven million people across 13 countries bring an end ... The GSF,s latest Progress Report details how its financial ... in over 20,500 communities become open-defecation free, improved toilets ... gain access to hand-washing facilities. The Progress ...
(Date:6/2/2015)... June 2, 2015 ... mejora  de 7,9 meses en la supervivencia libre ... con cáncer colorrectal metastático inoperable (mCRC) tratados  en ... Y-90 más quimioterapia    Los beneficios ... directamente al hígado con la quimioterapia sistémica actual ...
(Date:6/2/2015)... e MADRID , June 2, 2015 ... al meeting annuale della American Society of Clinical Oncology ... studio multicentrico di fase 3 SAR3007, resi noti dal ... (Janssen), hanno evidenziato un significativo miglioramento della sopravvivenza libera ... ® ) rispetto al trattamento con dacarbazina in pazienti ...
Breaking Medicine Technology:Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 2Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 3Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 4Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 5Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 6Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 7Se presenta el estudio SIRFLOX en la reunión anual ASCO 2015 8PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... certain mutations enable specific cells in the,retina to ... suggests deliberate,genetic manipulations might coax an injured brain ... Investigators at St.,Jude Children,s Research Hospital have ... cancer retinoblastoma, disproving a long-standing principle of,nerve growth ...
... Oct. 18 Mayo Clinic has,clarified the methods ... and,little-understood blood vessel disease of the brain and ... Primary central nervous system vasculitis,(PCNSV) can best be ... angiography (imaging the cerebral arteries), brain,biopsy and other ...
Cached Medicine Technology:St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 2St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 3Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord 2Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord 3
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Linda Cade as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to recognize Linda with this important honor,” said NAPW ...
(Date:6/1/2015)... 02, 2015 Dr. Robert ... Piedmont Physical Medicine & Rehabilitation, P.A., has published ... of stem cell therapy for knees, and highlights ... preferred alternative to arthroscopy or knee joint replacement. ... of Neuromusculoskeletal, Vascular and Regenerative Medicine, writes that ...
(Date:6/1/2015)... Houston, Texas (PRWEB) June 01, 2015 Unlike ... much as three times for in-use periods compared to when ... flat monthly rate whether the client uses the generator or ... guaranteed availability and delivery in as little as a few ... or desire to store a portable generator onsite. , “Even ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Rio Salado ... for children and young adults this summer. , The clinics ... 8 a.m. to 3 p.m. at the Rio Salado Dental ... in Tempe. , “A big goal for us is to ... experience for our students,” said Nikki Shipp, Clinical Coordinator for ...
(Date:6/1/2015)... Portland, Ore. (PRWEB) June 01, 2015 ... Plans (AHIP) announced today a new, interactive Affordable ... support large employers. The course, called “Affordable Care ... care professionals with the strategic and consultative insights ... employers as they navigate the impacts of the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 2Health News:New Article by Dr. Robert G. Schwartz of Piedmont Physical Medicine & Rehabilitation Looks at Benefits of Stem Cell Therapy for Knees 3Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Kids Receive Complimentary Dental Services at Rio Salado Dental Clinic 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3
... August is National Immunization Awareness Month , ... of Health Secretary Everette James today stressed the importance of ... , "Recommended vaccinations begin soon after birth and ... up-to-date on these immunizations is critical to protecting yourselves, your ...
... Delivery at 37 weeks helps women with hypertensive disorders, study ... be induced after 37 weeks in pregnant women with mild ... according to a new study in The Lancet . ... All had been pregnant 36 to 41 weeks and ...
... , TEMPLE, Texas, Aug. 3 Scott & White Healthcare ... conference in Washington, DC titled "How Do They Do That?; Low-Cost, High-Quality ... health care system and one of 10 health systems from across the ... The event was jointly hosted by The Institute for Healthcare ...
... , , MINNEAPOLIS, Aug. ... marketer of state-of-the-art cardiac surgery products and services, today reported financial results ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , , Second Quarter ... 17.0% higher than the second quarter of 2008. Revenue from the ...
... , Results , , ... DRRX ) announced today financial results for the three months ... months ended June 30, 2009, compared to $6.3 million for the same ... 30, 2009 was $7.5 million, compared to a net loss of $8.6 ...
... BIRMINGHAM, Ala., Aug. 3 ProAssurance ... $1.52 per diluted share for the second quarter of 2009. Net Income ... the six months ended June 30, 2009, Operating Income was $83.5 million, ... $2.46 per diluted share. , , (Logo: ...
Cached Medicine News:Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 2Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 3Health News:Induced Labor May Improve Outcome in Risky Pregnancies 2Health News:Scott & White Leadership Invited to National Forum on High Quality, Low-Cost Health Care 2Health News:ATS Medical Announces Second Quarter 2009 Results 2Health News:ATS Medical Announces Second Quarter 2009 Results 3Health News:ATS Medical Announces Second Quarter 2009 Results 4Health News:ATS Medical Announces Second Quarter 2009 Results 5Health News:ATS Medical Announces Second Quarter 2009 Results 6Health News:ATS Medical Announces Second Quarter 2009 Results 7Health News:ATS Medical Announces Second Quarter 2009 Results 8Health News:ATS Medical Announces Second Quarter 2009 Results 9Health News:ATS Medical Announces Second Quarter 2009 Results 10Health News:ATS Medical Announces Second Quarter 2009 Results 11Health News:DURECT Corporation Announces Second Quarter 2009 Financial 2Health News:DURECT Corporation Announces Second Quarter 2009 Financial 3Health News:DURECT Corporation Announces Second Quarter 2009 Financial 4Health News:DURECT Corporation Announces Second Quarter 2009 Financial 5Health News:DURECT Corporation Announces Second Quarter 2009 Financial 6Health News:DURECT Corporation Announces Second Quarter 2009 Financial 7Health News:DURECT Corporation Announces Second Quarter 2009 Financial 8Health News:DURECT Corporation Announces Second Quarter 2009 Financial 9Health News:ProAssurance Reports Second Quarter 2009 Results 2Health News:ProAssurance Reports Second Quarter 2009 Results 3Health News:ProAssurance Reports Second Quarter 2009 Results 4Health News:ProAssurance Reports Second Quarter 2009 Results 5Health News:ProAssurance Reports Second Quarter 2009 Results 6Health News:ProAssurance Reports Second Quarter 2009 Results 7Health News:ProAssurance Reports Second Quarter 2009 Results 8Health News:ProAssurance Reports Second Quarter 2009 Results 9Health News:ProAssurance Reports Second Quarter 2009 Results 10Health News:ProAssurance Reports Second Quarter 2009 Results 11Health News:ProAssurance Reports Second Quarter 2009 Results 12Health News:ProAssurance Reports Second Quarter 2009 Results 13
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting...
... range from 2ul to 5000ul. Fills and ... prevents inadvertent volume change. Novel hand grip ... is autoclavable at 121C(250F). To prevent corrosion ... for one-handed operation. Auto or Normal trigger ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Medicine Products: